vs
i3 Verticals, Inc.（IIIV）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是i3 Verticals, Inc.的1.3倍（$69.8M vs $52.7M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 0.9%，领先383.1%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -14.6%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs -4.7%）
Prusa i3是捷克Prusa Research公司生产的熔融沉积成型3D打印机系列，以Original Prusa i3为注册商标推出，同时也是RepRap项目的组成部分。2016年该系列就被评为全球使用率最高的3D打印机，最早由Josef Průša在2012年完成设计，2015年正式推出商用套件版本，目前最新型号同时提供散件套件和原厂组装版本，具备性价比高、易操作的优势。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
IIIV vs RIGL — 直观对比
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $52.7M | $69.8M |
| 净利润 | $484.0K | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 3.1% | 33.2% |
| 净利率 | 0.9% | 384.0% |
| 营收同比 | -14.6% | 21.2% |
| 净利润同比 | -76.5% | 1769.2% |
| 每股收益（稀释后） | $0.02 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $52.7M | $69.8M | ||
| Q3 25 | $46.0M | $69.5M | ||
| Q2 25 | $51.9M | $101.7M | ||
| Q1 25 | $63.1M | $53.3M | ||
| Q4 24 | $52.2M | $57.6M | ||
| Q3 24 | $32.0M | $55.3M | ||
| Q2 24 | $46.2M | $36.8M | ||
| Q1 24 | $58.0M | $29.5M |
| Q4 25 | $484.0K | $268.1M | ||
| Q3 25 | $3.1M | $27.9M | ||
| Q2 25 | $12.9M | $59.6M | ||
| Q1 25 | $-154.0K | $11.4M | ||
| Q4 24 | $2.1M | $14.3M | ||
| Q3 24 | $117.9M | $12.4M | ||
| Q2 24 | $-7.5M | $-1.0M | ||
| Q1 24 | $1.9M | $-8.2M |
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
| Q4 25 | 3.1% | 33.2% | ||
| Q3 25 | 3.2% | 40.9% | ||
| Q2 25 | -9.3% | 60.1% | ||
| Q1 25 | 8.0% | 23.9% | ||
| Q4 24 | 3.9% | 28.9% | ||
| Q3 24 | 10.6% | 25.4% | ||
| Q2 24 | -2.8% | 1.2% | ||
| Q1 24 | 3.4% | -23.6% |
| Q4 25 | 0.9% | 384.0% | ||
| Q3 25 | 6.7% | 40.2% | ||
| Q2 25 | 24.8% | 58.6% | ||
| Q1 25 | -0.2% | 21.5% | ||
| Q4 24 | 3.9% | 24.9% | ||
| Q3 24 | 368.2% | 22.5% | ||
| Q2 24 | -16.3% | -2.8% | ||
| Q1 24 | 3.2% | -27.9% |
| Q4 25 | $0.02 | $14.11 | ||
| Q3 25 | $0.14 | $1.46 | ||
| Q2 25 | $0.50 | $3.28 | ||
| Q1 25 | $0.00 | $0.63 | ||
| Q4 24 | $0.08 | $0.82 | ||
| Q3 24 | $4.93 | $0.70 | ||
| Q2 24 | $-0.32 | $-0.06 | ||
| Q1 24 | $0.08 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $37.5M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $358.5M | $391.5M |
| 总资产 | $595.9M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
| Q4 25 | $37.5M | $155.0M | ||
| Q3 25 | $66.7M | $137.1M | ||
| Q2 25 | $55.5M | $108.4M | ||
| Q1 25 | $7.7M | $77.1M | ||
| Q4 24 | $85.6M | $77.3M | ||
| Q3 24 | $86.5M | $61.1M | ||
| Q2 24 | $9.7M | $49.1M | ||
| Q1 24 | $3.1M | $49.5M |
| Q4 25 | — | $52.5M | ||
| Q3 25 | $0 | $60.0M | ||
| Q2 25 | $0 | $60.0M | ||
| Q1 25 | $12.0M | $60.0M | ||
| Q4 24 | $26.2M | $60.0M | ||
| Q3 24 | $26.2M | $60.0M | ||
| Q2 24 | $374.1M | $60.0M | ||
| Q1 24 | $369.6M | $60.0M |
| Q4 25 | $358.5M | $391.5M | ||
| Q3 25 | $389.6M | $117.6M | ||
| Q2 25 | $383.3M | $81.9M | ||
| Q1 25 | $385.2M | $18.6M | ||
| Q4 24 | $375.0M | $3.3M | ||
| Q3 24 | $379.7M | $-14.6M | ||
| Q2 24 | $249.7M | $-29.9M | ||
| Q1 24 | $249.3M | $-31.7M |
| Q4 25 | $595.9M | $513.6M | ||
| Q3 25 | $638.4M | $242.5M | ||
| Q2 25 | $623.3M | $206.7M | ||
| Q1 25 | $646.4M | $176.0M | ||
| Q4 24 | $726.2M | $164.0M | ||
| Q3 24 | $730.7M | $139.4M | ||
| Q2 24 | $861.7M | $128.4M | ||
| Q1 24 | $625.8M | $126.5M |
| Q4 25 | — | 0.13× | ||
| Q3 25 | 0.00× | 0.51× | ||
| Q2 25 | 0.00× | 0.73× | ||
| Q1 25 | 0.03× | 3.23× | ||
| Q4 24 | 0.07× | 18.25× | ||
| Q3 24 | 0.07× | — | ||
| Q2 24 | 1.50× | — | ||
| Q1 24 | 1.48× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.1M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $13.8M | — |
| 自由现金流率自由现金流/营收 | 26.2% | — |
| 资本支出强度资本支出/营收 | 0.6% | — |
| 现金转化率经营现金流/净利润 | 29.18× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $6.5M | — |
8季度趋势，按日历期对齐
| Q4 25 | $14.1M | $22.0M | ||
| Q3 25 | $14.0M | $24.0M | ||
| Q2 25 | $7.4M | $30.5M | ||
| Q1 25 | $-27.1M | $-893.0K | ||
| Q4 24 | $11.5M | $14.5M | ||
| Q3 24 | $15.1M | $21.7M | ||
| Q2 24 | $8.1M | $302.0K | ||
| Q1 24 | $10.7M | $-5.0M |
| Q4 25 | $13.8M | — | ||
| Q3 25 | $13.5M | — | ||
| Q2 25 | $6.8M | — | ||
| Q1 25 | $-27.6M | — | ||
| Q4 24 | $11.0M | — | ||
| Q3 24 | $14.6M | — | ||
| Q2 24 | $7.2M | — | ||
| Q1 24 | $9.9M | — |
| Q4 25 | 26.2% | — | ||
| Q3 25 | 29.5% | — | ||
| Q2 25 | 13.1% | — | ||
| Q1 25 | -43.8% | — | ||
| Q4 24 | 21.1% | — | ||
| Q3 24 | 45.6% | — | ||
| Q2 24 | 15.6% | — | ||
| Q1 24 | 17.1% | — |
| Q4 25 | 0.6% | — | ||
| Q3 25 | 0.9% | — | ||
| Q2 25 | 1.0% | — | ||
| Q1 25 | 0.8% | — | ||
| Q4 24 | 0.9% | — | ||
| Q3 24 | 1.7% | — | ||
| Q2 24 | 1.9% | — | ||
| Q1 24 | 1.4% | — |
| Q4 25 | 29.18× | 0.08× | ||
| Q3 25 | 4.52× | 0.86× | ||
| Q2 25 | 0.57× | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | 5.59× | 1.01× | ||
| Q3 24 | 0.13× | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | 5.72× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IIIV
| License And Service | $35.7M | 68% |
| Proprietary Payments Revenue | $14.5M | 27% |
| Other Revenue | $2.5M | 5% |
RIGL
暂无分部数据
